Single-Cell Transcriptomics Reveals Tumorigenic Lineages and Interactions Persisting and Evolving From Premalignancy to Cancer in the Stomach

Authors:

Abstract
Background & Aims: Gastric cancer is often diagnosed at advanced stages, making the premalignant window critical for early detection. However, the epithelial changes that characterize this stage remain poorly defined. We used CTLA4-knockdown (CTLA4KD) mice, which model human CTLA4 insufficiency-associated gastric cancer, that develops autoimmune gastritis, metaplasia, and adenocarcinoma, to define molecular changes across disease progression. Methods: Single-cell RNA sequencing and 40-color spectral flow cytometry were performed on gastric tissue across premalignant and cancer stages. We evaluated epithelial lineage relationships, cell-cell communication pathways, and candidate markers at the transcript and protein levels in murine and human gastric adenocarcinoma. Results: We identified a metaplastic/tumorigenic population in CTLA4KD mice that emerged in premalignancy with a chief cell transcriptomic origin. Cell-cell communication analysis revealed a progressive increase in fibronectin (FN1) signaling from premalignancy through cancer, transitioning from stromal to autocrine signaling in the metaplastic/tumorigenic population. Expression of Embigin (EMB), a fibronectin receptor, increased at both transcript and protein levels in premalignancy and remained elevated in cancer. EMB⁺ epithelial cells co-expressed CD133, a cancer stem cell marker, consistent with a stem-like phenotype. EMB expression was also higher in human gastric adenocarcinoma than in matched normal tissue. Conclusions: Using a model that captures the full histopathological cascade of gastric tumorigenesis, we delineate single-cell transcriptional programs that persist and evolve from premalignancy to adenocarcinoma. In-depth computational analyses identified novel markers involved in cell-cell communication during tumorigenesis, including EMB, an epithelial marker that persists from premalignancy through cancer in the murine model and validated in human gastric adenocarcinoma, suggesting EMB as a marker of premalignant progression. Graphic What You Need to Know: Background and Context: The cellular and molecular changes that drive gastric premalignancy toward invasive cancer remain poorly defined, leaving no reliable way to identify which premalignant lesions will progress. New Findings: We identified a tumorigenic epithelial population present in premalignancy and persisting into cancer, accompanied by increased fibronectin signaling and sustained Embigin expression across disease progression. Limitations: We defined the premalignant-to-cancer transition in a mouse model and validated a marker in human gastric adenocarcinoma. Single-cell studies of human gastric premalignancy to cancer progression are needed to confirm these findings. Clinical Research Relevance: Defining epithelial changes that persist from premalignancy through cancer may help distinguish lesions progressing toward malignancy from those remaining stable. Embigin may represent a candidate marker of this transition, supporting future studies aimed at improving risk stratification and earlier identification of patients most likely to develop gastric cancer. Basic Research Relevance: This study defines cellular and molecular changes during the transition from gastric premalignancy to cancer. It identifies a tumorigenic population arising from chief cells that persists across disease stages, as well as changes in fibronectin signaling and Embigin expression associated with progression of premalignancy toward invasive cancer. Lay Summary: We identified markers of stomach cells on the pathway to becoming cancer cells in animal models, and these markers may provide a tool for early detection before invasive cancer develops.

This publication has 56 references indexed in Scilit: